CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: December-18-13
Credit Expiration Date: December-18-14


Program Chair
Peter P. Toth, MD, PhD
Director of Preventive Cardiology
Sterling Rock Falls Clinic, Ltd.
Chief of Medicine, CGH Medical Center
Sterling, IL 
Clinical Professor
University of Illinois School of Medicine
Peoria, IL

Credit Hours




Program Description

For many years, it has been recognized that elevated serum levels of high-density lipoprotein cholesterol (HDL-C) are associated with reduced risk of cardiovascular disease (CVD). Because many prospective observational studies have confirmed an inverse relationship between HDL-C and cardiovascular risk, it was assumed that raising HDL-C through lifestyle modifications and pharmacologic interventions could reduce the risk of CVD. However, recent randomized studies have failed to demonstrate this hypothesized benefit. The 3-part CME-certified interactive newsletter series “Managing Residual Cardiovascular Disease Risk: The Role of HDL Cholesterol” recently examined the complex relationship between HDL-C and atherosclerotic vascular disease.

This 2013 Update will review findings since the publication of the first 3 issues in the series and provide commentary about future directions for research.

Program Developer/Facilitator


Target Audience

Lipidologists, cardiologists, primary care physicians, nurse practitioners, physician assistants, and other clinicians who treat patients with dyslipidemia/residual CVD risk.

Learning Objectives

Upon completion of this knowledge-based educational activity, the participant should be able to:

  1. Review 2013 findings with regard to the relationship between HDL-C and cardiovascular risk.


Peter P. Toth, MD, PhD, discloses that he has served as a consultant for Abbott Laboratories, Inc.; AstraZeneca; Kowa Pharmaceuticals America Inc.; Amgen; Amylin Pharmaceuticals; and Merck and Co., Inc. He has served on the speakers' bureaus of Abbott Laboratories, Inc.; AstraZeneca; Boehringer Ingelheim; Merck & Co., Inc.; Kowa Pharmaceuticals America, Inc.; GlaxoSmithKline; and Amylin Pharmaceuticals.

NLA planners and managers have nothing to disclose.

MCM Education planners and managers have nothing to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure Declaration
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Credit Statements

CME credit provided by the National Lipid Association.

The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Lipid Association designates this enduring internet activity for a maximum of 0.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits from organizations accredited by ACCME.

Commercial Support Statements

This activity is supported by an educational grant from Genentech, USA.


Minimum System Requirements
• Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

  1. After the activity has finished, click on the "Post-test" button.
  2. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
  3. Please turn off all pop-up blockers to ensure access to the educational activity.
  4. Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  5. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 15 minutes to complete.

Certificate Fee



This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu